3 Matching Annotations
  1. Last 7 days
    1. Case#: Ye_2022_PL16, male, 1.5 yr (onset), Caucasian ancestry reported

      DiseaseAssertion: APDS

      FamilyInfo: affected, genotype positive half-sibling F2P2 in PMID: 24610295. In this article, identified as PL17. Shared mother most likely has germinal mosaicism.

      CasePresentingHPOs: lymphoma (HP:0002665), elevated IgM (HP:0003496) recurrent severe sinopulmonary infections (HP:0005425) otitis media (HP:0000388) lymphadenitis (HP:0002840) rectal abscesses (HP:0005224) cellulitis (HP:0100658) bronchiectasis (HP:0002110) lymphoproliferation (HP:0005523) eczematous dermatitis (HP:0000964) HSV super-infection (HP:0005353) dysmorphic facial features (HP:0001999) osteoporosis complicated by vertebral collapse (HP:0000939) nephrolithiasis (HP:0000787) cholelithiasis (HP:0001081)

      CaseHPOFreeText: elevated CD3+ percentage pneumococcal sepsis hypertrophy of lymphoid tissues in the GI tract delayed sexual maturation poor vaccine response

      CaseNotHPOs: abnormal IgG (HP:0410242) abnormal IgA (HP:0410240) abnormal lymphocyte count (HP:0040088)

      CaseNotHPOFreeText: abnormal B-cell count abnormal CD4+ percentage abnormal CD8+ percentage abnormal NK percentage

      CasePreviousTesting:

      GenotypingMethod: Targeted sequencing panel of 715 cancer-related genes

      PreviouslyPublished: Yes, F2P3 in Crank 2014 (PMID:24610295)

      Variant: c.1246T>C, p.C416R

      ClinVarID: 132808

      CAID:

      gnomAD: NR

      SupplementalData: S2 provides more information on the lymphoma.

    2. Case#: Ye_2022_PL18, female, 1.5 yr (onset), Caucasian ancestry reported

      DiseaseAssertion: APDS

      FamilyInfo: family info unreported. Pedigree in Crank 2014 shows potential de novo occurance, but this is not confirmed or commented on.

      CasePresentingHPOs: lymphoma (HP:0002665), elevated IgG (HP:0003237), elevated IgM (HP:0003496), decreased B-cell percentage (HP:0010976), recurrent otitis media (HP:0000403), recurrent sinopulmonary infection (HP:0005425), lymphadenopathy (HP:0002716), splenomegaly (HP:0001744), lymphoproliferation (HP:0005523), immune thrombocytopenia (HP:0001973),

      CaseHPOFreeText: low CD3+ percentage, decreased CD4+ percentage, elevated NK percentage, decreased vaccine response,

      CaseNotHPOs: abnormal IgA (HP:0410240), abnormal lymphocyte count (HP:0040088), abnormal B-cell count (HP:0010975),

      CaseNotHPOFreeText: abnormal CD8+ percentage, EBV and CMV

      CasePreviousTesting:

      GenotypingMethod: Sanger sequencing in original article. These authors perform an additional WES from a blood sample. WES of tumor also performed to identify somatic variation.

      PreviouslyPublished: Crank 2014 (PMID:24610295)

      Variant: c.3061G>A, p.E1021K

      ClinVarID: 88675

      CAID:

      gnomAD: NR

      SupplementalData: S2 provides more information on the lymphoma.

  2. Jan 2024
    1. once an avascular or bloodless cancer 00:22:48 is able to get vessels to touch it that moment that touch is that the cancer can grow 16 000 times in two weeks

      for - avascular (bloodless) cancer - angiogenesis creates malignancy - stats - angiogenesis and avascular cancer

      stats - angiogenisis and avascular cancer - During research, the research lab that William Li worked in discovered that once blood vessesl touch a harmless avascular (bloodless) cancer - it transforms it into a deadly, malignant tumor that grows 16,000x in two weeks